Searched for
NATCO PHARMA ACQUISITION
Natco Pharma to acquire significant stake in S African firm Adcock IngramIndian pharmaceutical company Natco Pharma is set to acquire significant stakes in South Africa's Adcock Ingram, a 135-year-old firm, in a ...- Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock IngramNatco’s proposed all-cash deal to acquire nearly 36% of AIHL from minority shareholders is aimed at expanding its presence in South Africa,...
- Natco Pharma to buy over 35% in South Africa's Adcock IngramNatco Pharma, based in Hyderabad, is set to acquire a 35.75% stake in Adcock Ingram, South Africa's second-largest drugmaker, for ₹2,000 cr...
- Natco Pharma offers to acquire nearly 36% stake in Adcock Ingram in Rs 2,100-cr dealNatco Pharma has made a firm offer to acquire nearly 36% stake in South African drug firm Adcock Ingram Holdings for up to Rs 2,100 crore. ...
- NATCO Pharma shares sinks 28% in 2 days on Q3 earnings miss, brokerage downgradeNATCO Pharma shares tumbled 10% on Friday, extending a two-day slump to 28% after weak Q3 results and a target price cut by Nuvama. Profit ...
- Microsoft India buys Rs 181.25 crore land parcel near Hyderabad from Natco PharmaMicrosoft has acquired a 121,000 sq yard land parcel near Hyderabad for ₹181.25 crore from Natco Pharma, adding to its growing land bank in...
- Hot Stocks: Brokerages on RIL, Entero Healthcare, Natco Pharma and Persistent SystemsBrokerage Nomura upheld a neutral rating on Persistent Systems, while Investec continues to advocate a buy stance on Natco Pharma and has i...
- Stocks in news: ZEE Entertainment, Natco Pharma, Ajanta Pharma, Hero MotoCorpZEE Studios and IPRS (Indian Performing Right Society) have entered into a settlement agreement by which all disputes and claims have been ...
- Natco Pharma proposes to acquire Dash PharmaceuticalsAccording to a press release issued by the Hyderabad-based drug maker, Dash is a front-end pharmaceutical sales, marketing and distribution...
- Regulatory concerns weighing on largecap pharma stocks: Kunj BansalIt is obvious that if largecap companies are going through regulatory pressures, the same applies to midcaps as well, says Bansal.
- Teva’s hostile bid for Mylan: Deal could open up a $2-billion opportunity for pharma companiesAccording to experts, there is a possibility that the fruition of the deal will open up a $2-billion opportunity for Indian generic pharma ...
- Dilip Shanghvi, Sun Pharma promoter, a pharma maven with midas touchThe only investment which has not yet borne fruit for Shanghvi is his stake in BioLight Israeli Life Sciences Investments, which is listed ...
- Cipla, Mylan in race to buy select brands of Sun Pharma put up for saleThe total value of the seven drugs is estimated to be close to Rs 137 crore according to data available with AIOCDA.
- Non-compete clause for FDI in pharmaceutical companies will not be applicable: Reserve Bank of IndiaThe RBI today said the non-compete clause will not be applicable in acquisition of existing pharma cos by foreign entities except in specia...
- Five midcap stocks that can give good returns in medium termAnalysts are of the view that valuations of some of the midcap stocks have become attractive after the recent sharp correction.
- Pharma MNCs GSK, Merck, Pfizer and others prefer tie-ups over acquisitions with Indian firmsWith Indian drug makers flooding the developed markets, GSK, Merck, Pfizer now prefer tie-ups over acquisitions with Indian players.
- Heard on the Street: Natco Pharma, Guar FuturesAt a time when many companies are deferring their fund-raising plans, Natco Pharma has proved an exception to this trend, albeit unfavourab...
- Natco Pharma completes acquisition of Newark DrugsNatco Pharma has reported the completion of purchase of assets of Newark Drugs, a retail pharmacy store based in Newark, New Jersey, US.
- Natco close to buying two US retail storesThe South India-based Natco Pharma is understood to be close to acquiring two standalone retail stores in the US.
- Buzz on Natco Pharma over land bankThe buzz at the Natco Pharma that it has a land bank valued at close to Rs 350 crore near Hyderabad airport. Supporters of the stock claim ...
Load More
